Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)
CRDL moved a median of -0.29% 30 minutes after news, and 0.00% by the close. How CRDL actually reacts to news — the realized, point-in-time move the market made, measured across 128 labeled events over the last three years with zero look-ahead.
CRDL’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 44% | 126 |
| 30-min | -0.29% | 42% | 128 |
| 60-min | 0.00% | 42% | 128 |
| to close | 0.00% | 44% | 127 |
| Middle 50% of CRDL reactions | -1.98% to +1.48% |
|---|---|
| Median reaction (30-min) | -0.29% |
| Measured reactions | 128 |
Half of all Cardiol Therapeutics Inc. - Class A Common Shares news events land between -1.98% and +1.48% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How CRDL reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Coverage initiations | 15 | -4.61% | 13% | -5.38% |
| Rating reiterations | 28 | -0.79% | 39% | -1.92% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how CRDL ranks against every other measured name →
That’s how CRDL usually reacts — get an email when it moves on news →Email me when CRDL moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CRDL's baseline. Nothing else.
Recent CRDL events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s Efficacy | Press release | Canada Newswire | +0.54% | -4.32% | |
| Form 6-K Cardiol Therapeutics For: Sep 23 | SEC filing · Form 6-K | SEC EDGAR | +0.54% | -4.32% | |
| Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds | Press release | Canada Newswire | +1.08% | +2.70% | |
| Form 6-K Cardiol Therapeutics For: Sep 16 | SEC filing · Form 6-K | SEC EDGAR | +1.08% | +2.70% | |
| Form F-10/A Cardiol Therapeutics | SEC filing · Form F-10 | SEC EDGAR | -0.01% | +2.70% | |
| Form SUPPL Cardiol Therapeutics | SEC filing · Form SUPPL | SEC EDGAR | -0.55% | +4.11% | |
| Form 6-K Cardiol Therapeutics For: Sep 14 | SEC filing · Form 6-K | SEC EDGAR | -0.15% | -5.61% | |
| Form 6-K Cardiol Therapeutics For: Sep 10 | SEC filing · Form 6-K | SEC EDGAR | +0.25% | -1.72% | |
| Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities Commission | Press release | Canada Newswire | +0.25% | -1.72% | |
| Form 6-K Cardiol Therapeutics For: Sep 10 | SEC filing · Form 6-K | SEC EDGAR | +0.25% | -1.72% | |
| Form F-10 Cardiol Therapeutics | SEC filing · Form F-10 | SEC EDGAR | +0.00% | -8.97% | |
| Cardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment Conference | Press release | Canada Newswire | +0.00% | +2.93% | |
| Form 6-K Cardiol Therapeutics For: Sep 09 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +2.93% | |
| Form 6-K Cardiol Therapeutics For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +6.71% | +14.77% | |
| Cardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth Conference | Press release | Canada Newswire | +0.73% | -1.47% | |
| Form 6-K Cardiol Therapeutics For: Aug 05 | SEC filing · Form 6-K | SEC EDGAR | +0.73% | -1.47% | |
| Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association | Press release | Canada Newswire | +0.00% | +6.48% | |
| Form 6-K Cardiol Therapeutics For: Jul 14 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +6.48% | |
| Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit | Press release | Canada Newswire | -0.49% | -1.78% | |
| Form 6-K Cardiol Therapeutics For: Jul 09 | SEC filing · Form 6-K | SEC EDGAR | -0.49% | -1.78% | |
| Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders | Press release | Canada Newswire | +0.95% | -0.95% | |
| Form 6-K Cardiol Therapeutics For: Jun 25 | SEC filing · Form 6-K | SEC EDGAR | +0.95% | -0.95% | |
| Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT | Press release | Canada Newswire | +0.47% | -0.94% | |
| Form 6-K Cardiol Therapeutics For: Jun 23 | SEC filing · Form 6-K | SEC EDGAR | +0.47% | -0.94% | |
| Form 6-K Cardiol Therapeutics For: May 25 | SEC filing · Form 6-K | SEC EDGAR | -1.53% | -2.98% | |
| Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ | Press release | Canada Newswire | +0.00% | +0.00% | |
| Form 6-K Cardiol Therapeutics For: May 14 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 6-K Cardiol Therapeutics For: Mar 31 | SEC filing · Form 6-K | SEC EDGAR | -0.75% | +1.50% | |
| Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association | Press release | Canada Newswire | +2.31% | +0.00% | |
| Form 6-K Cardiol Therapeutics For: May 07 | SEC filing · Form 6-K | SEC EDGAR | +2.31% | +0.00% | |
| Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program | Press release | Canada Newswire | -2.48% | -2.84% | |
| Form 6-K Cardiol Therapeutics For: Apr 28 | SEC filing · Form 6-K | SEC EDGAR | -2.48% | -2.84% | |
| Form 6-K Cardiol Therapeutics For: Apr 14 | SEC filing · Form 6-K | SEC EDGAR | +4.82% | +3.70% | |
| Form 6-K Cardiol Therapeutics For: Apr 10 | SEC filing · Form 6-K | SEC EDGAR | — | -1.43% | |
| Form 6-K Cardiol Therapeutics For: Apr 01 | SEC filing · Form 6-K | SEC EDGAR | +4.50% | +2.94% | |
| Form 40-F Cardiol Therapeutics For: Dec 31 | SEC filing · Form 40-F | SEC EDGAR | +4.50% | +2.94% | |
| Form 6-K Cardiol Therapeutics For: Feb 25 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 6-K Cardiol Therapeutics For: Feb 10 | SEC filing · Form 6-K | SEC EDGAR | +0.48% | +3.85% | |
| Form 6-K Cardiol Therapeutics For: Jan 23 | SEC filing · Form 6-K | SEC EDGAR | +1.53% | +4.08% | |
| Form 6-K Cardiol Therapeutics For: Jan 26 | SEC filing · Form 6-K | SEC EDGAR | -0.19% | +0.00% | |
| Form 6-K Cardiol Therapeutics For: Jan 23 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +0.97% | |
| Form 6-K Cardiol Therapeutics For: Jan 16 | SEC filing · Form 6-K | SEC EDGAR | -1.31% | +7.07% | |
| Form 6-K Cardiol Therapeutics For: Jan 13 | SEC filing · Form 6-K | SEC EDGAR | -2.25% | -2.76% | |
| Form 6-K Cardiol Therapeutics For: Dec 01 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -13.64% | |
| Form 6-K Cardiol Therapeutics For: Nov 13 | SEC filing · Form 6-K | SEC EDGAR | -2.36% | — | |
| Form 6-K Cardiol Therapeutics For: Nov 05 | SEC filing · Form 6-K | SEC EDGAR | +0.95% | +3.81% | |
| Form F-10 Cardiol Therapeutics | SEC filing · Form F-10 | SEC EDGAR | +0.21% | -4.67% | |
| Form SUPPL Cardiol Therapeutics | SEC filing · Form SUPPL | SEC EDGAR | +0.21% | -4.67% | |
| Form D Cardiol Therapeutics | SEC filing · Form D | SEC EDGAR | +0.95% | +3.81% | |
| Form 6-K Cardiol Therapeutics For: Oct 27 | SEC filing · Form 6-K | SEC EDGAR | -2.46% | -4.10% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CRDL section they belong to.
Where else CRDL is measured.
CRDL earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Cardiol Therapeutics Inc. - Class A Common Shares's median reaction calculated?
Every labeled CRDL news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 128 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 42% of CRDL's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CRDL's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.